更正：美国炎症性肠病队列中皮质类固醇的使用与并发症
Correction: Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.
作者信息
Waljee Akbar K, Wiitala Wyndy L, Govani Shail, Stidham Ryan, Saini Sameer, Hou Jason, Feagins Linda A, Khan Nabeel, Good Chester B, Vijan Sandeep, Higgins Peter D R
出版信息
PLoS One. 2018 May 9;13(5):e0197341. doi: 10.1371/journal.pone.0197341. eCollection 2018.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0158017.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0158017。]
相似文献
1
Correction: Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.
PLoS One. 2018 May 9;13(5):e0197341. doi: 10.1371/journal.pone.0197341. eCollection 2018.
2
Correction: Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease.
PLoS One. 2017 Feb 21;12(2):e0172872. doi: 10.1371/journal.pone.0172872. eCollection 2017.
3
Correction: Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
PLoS One. 2017 Feb 2;12(2):e0170865. doi: 10.1371/journal.pone.0170865. eCollection 2017.
4
Correction: Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease.
PLoS One. 2018 Sep 4;13(9):e0203709. doi: 10.1371/journal.pone.0203709. eCollection 2018.
5
Correction: Evidence-Based Neonatal Unit Practices and Determinants of Postnatal Corticosteroid-Use in Preterm Births below 30 Weeks GA in Europe. A Population-Based Cohort Study.
PLoS One. 2017 Feb 13;12(2):e0172408. doi: 10.1371/journal.pone.0172408. eCollection 2017.
6
Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
PLoS One. 2017 Apr 6;12(4):e0175659. doi: 10.1371/journal.pone.0175659. eCollection 2017.
7
Correction: Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease.
PLoS One. 2019 Feb 5;14(2):e0212148. doi: 10.1371/journal.pone.0212148. eCollection 2019.
8
Correction: Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics.
PLoS One. 2019 May 7;14(5):e0216768. doi: 10.1371/journal.pone.0216768. eCollection 2019.
9
Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.
PLoS One. 2017 Dec 6;12(12):e0189551. doi: 10.1371/journal.pone.0189551. eCollection 2017.
10
Correction: Vitamin D status in pediatric irritable bowel syndrome.
PLoS One. 2017 Mar 9;12(3):e0173779. doi: 10.1371/journal.pone.0173779. eCollection 2017.
本文引用的文献
1
Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.
PLoS One. 2016 Jun 23;11(6):e0158017. doi: 10.1371/journal.pone.0158017. eCollection 2016.
Zotero 插件